Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly \u00a3161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory treatment normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19.
The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.
Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.
Oxford is one of 28 sites that will benefit from over \u00a3160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
A new analysis from Oxford Population Health has found that pregnant women that are 30 years old or more, overweight, of mixed ethnicity or have gestational diabetes have a greater risk of contracting severe COVID-19, which poses significant risks for both mother and baby.
Researchers from the University of Oxford\u2019s Big Data Institute have taken a major step towards mapping the entirety of genetic relationships among humans: a single genealogy that traces the ancestry of all of us.
A team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.
The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.
INTERCOVID-2022: The University of Oxford is to launch the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.
Two Department of Physiology, Anatomy and Genetics (DPAG) projects aimed at tackling heart failure are to be funded by the 2022 TCS London Marathon with the British Heart Foundation (BHF) as its Charity of the Year, as two of eight handpicked BHF projects.
Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in Parkinson\u2019s-like Multiple Systems Atrophy (MSA).
As part of World Cancer Day 2022 we are diving into 10 of Oxford\u2019s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.
Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.
This campaign was led by a team of 29 Early Career Researchers (ECRs) and a Young People's Advisory Group (YPAG) across five African countries. The young people wanted to share contextual and accessible information on digital mental health and ethical issues that are important to them.
![\"3D](\"https://www.medsci.ox.ac.uk/news/brain-regions-related-to-smell-show-decline-following-mild-covid-19/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n